Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin Meng

Showing results (281-290 of 341) with videos related to

Pageof 35
Sort By:
Cell Death & Disease|July 10, 2020
ISG15 induces ESRP1 to inhibit lung adenocarcinoma progressionTongyuan Qu, Wenshuai Zhang, Lisha Qi, et al.
Oncotarget|February 27, 2016
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodesHuan-Huan Wang, Nicholas G Zaorsky, Mao-Bin Meng, et al.
Journal of Immunology Research|November 12, 2020
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells and Survival in Diffuse Large B Cell LymphomaTingting Zhang, Tianyuan Ren, Zheng Song, et al.
Clinical Immunology (Orlando, Fla.)|September 2, 2022
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphomaXiaoxuan Wang, Yuheng Hong, Shen Meng, et al.
British Journal of Haematology|October 19, 2021
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNASicong Zhang, Tingting Zhang, Hengqi Liu, et al.
Frontiers in Oncology|August 2, 2021
An Immune-Clinical Prognostic Index (ICPI) for Patients With <i>De Novo</i> Follicular Lymphoma Treated With R-CHOP/CHOP ChemotherapyYaxiao Lu, Jingwei Yu, Wenchen Gong, et al.
Cancer Science|August 30, 2019
Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancerMao-Bin Meng, Huan-Huan Wang, Nicholas G Zaorsky, et al.
British Journal of Haematology|February 11, 2020
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myelomaXuan Wu, Jiliang Xia, Jingyu Zhang, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2023
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphomaYaxiao Lu, Yang Li, Jingwei Yu, et al.
Oncotargets and Therapy|June 25, 2014
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastasesZhi-Yong Yuan, Mao-Bin Meng, Chun-Lei Liu, et al.
Pageof 35

Showing results (281-290 of 341) with videos related to

Sort By:
Pageof 35
Cell Death & Disease|July 10, 2020
ISG15 induces ESRP1 to inhibit lung adenocarcinoma progressionTongyuan Qu, Wenshuai Zhang, Lisha Qi, et al.
Oncotarget|February 27, 2016
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodesHuan-Huan Wang, Nicholas G Zaorsky, Mao-Bin Meng, et al.
Journal of Immunology Research|November 12, 2020
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells and Survival in Diffuse Large B Cell LymphomaTingting Zhang, Tianyuan Ren, Zheng Song, et al.
Clinical Immunology (Orlando, Fla.)|September 2, 2022
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphomaXiaoxuan Wang, Yuheng Hong, Shen Meng, et al.
British Journal of Haematology|October 19, 2021
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNASicong Zhang, Tingting Zhang, Hengqi Liu, et al.
Frontiers in Oncology|August 2, 2021
An Immune-Clinical Prognostic Index (ICPI) for Patients With <i>De Novo</i> Follicular Lymphoma Treated With R-CHOP/CHOP ChemotherapyYaxiao Lu, Jingwei Yu, Wenchen Gong, et al.
Cancer Science|August 30, 2019
Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancerMao-Bin Meng, Huan-Huan Wang, Nicholas G Zaorsky, et al.
British Journal of Haematology|February 11, 2020
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myelomaXuan Wu, Jiliang Xia, Jingyu Zhang, et al.
Clinical Immunology (Orlando, Fla.)|May 7, 2023
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphomaYaxiao Lu, Yang Li, Jingwei Yu, et al.
Oncotargets and Therapy|June 25, 2014
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastasesZhi-Yong Yuan, Mao-Bin Meng, Chun-Lei Liu, et al.
Pageof 35